Direct Rx: Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
- Recall status
- Ongoing (still active)
- Severity
- Class II: could cause temporary or reversible health problems What recall classes mean
- Where sold
- Nationwide within the United States
Common questions
- Is Direct Rx Lidocaine Ointment USP 5.0 % 50g JAR recalled?
- Yes. FDA (drug) recalled Direct Rx Lidocaine Ointment USP 5.0 % 50g JAR on 2026-11-04. Recall status: Ongoing (still active).
- What is the hazard?
- Subpotent Drug
- Where was it sold?
- Nationwide within the United States
Read the official notice at FDA (drug) →
More recalls
- Direct Rx: DULOXETINE D/R, a) 30 mg (NDC 61919-482-30), 30 Caps; b) 30 mg (NDC
- bioQuad Life Sciences: OsteoDenx capsules
- Game Changer Products, LLC: 10 Day Forecast Capsules 3200mg
- Eugia US LLC: Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single
- Trifluent Pharma LLC: Tridacaine III / Lidocaine Patch 5%, 15 envelopes
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Direct Rx
- Product
- Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
- Reason / hazard
- Subpotent Drug
- What to do (remedy)
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the United States
- Recall initiated
- 2026-09-29
- Code info
- LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.
- Product quantity
- 493 jars
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Dawsonville
- State
- GA
- Country
- United States
- Event id
- 100229
Free daily digest + "My products" watchlist